Therefore, we hypothesized that treatment targeting NF-κB signaling potentially also produced inhibitory effects on ACE2 level, which was important for the prevention and clinical treatment of COVID-19 infection and the infection-caused inflammatory cytokine storm. This evidence concerns the gene ACE2 and infection.